Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Cubist Pharmaceuticals
Cubist Pharmaceuticals
Trius Acquired Last Week, Tetraphase Could Be Next
Seeking Alpha
Tue, 08/6/13 - 10:19 am
Trius Therapeutics
M&A
Tetraphase Pharmaceuticals
Cubist Pharmaceuticals
Optimer Pharmaceuticals
Pfizer
SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Trius Therapeutics, Inc. in Connection with the Sale of Company to Cubist Pharmaceuticals, Inc.
Yahoo/BusinessWire
Wed, 07/31/13 - 09:54 am
Cubist Pharmaceuticals
Trius Therapeutics
M&A
lawsuits
Cubist Pharmaceuticals to Acquire Optimer Pharmaceuticals
Yahoo/BusinessWire
Wed, 07/31/13 - 09:53 am
Cubist Pharmaceuticals
Optimer Pharmaceuticals
M&A
Cubist Pharmaceuticals to Acquire Trius Therapeutics
Yahoo/BusinessWire
Wed, 07/31/13 - 09:51 am
Cubist Pharmaceuticals
Trius Therapeutics
M&A
Cubist Pharmaceuticals: Doomsday Preparation Update
Seeking Alpha
Fri, 07/26/13 - 09:07 am
Cubist Pharmaceuticals
Cubicin
generics
antiobiotics
Anatomy of an Earnings Jump: Cubist Pharmaceuticals
Motley Fool
Tue, 07/23/13 - 11:13 am
earnings
Cubist Pharmaceuticals
Earnings Miss at Cubist Pharma
Yahoo/Zacks
Fri, 07/19/13 - 11:31 am
Cubist Pharmaceuticals
earnings
Cempra's Platform Potentially Worth Billions In Battling Superbugs And MRSA
Seeking Alpha
Tue, 06/25/13 - 12:20 pm
Cempra
superbugs
Cubist Pharmaceuticals
Ariad Pharmaceuticals
Celldex
Trius Therapeutics
2013 FDA Drug Approval Calendar
TheStreet.com
Tue, 05/21/13 - 12:05 pm
drug approvals
GSK
Dolutegravir
Trametenib
Auxilium
Xiaflex
Delcath
Melblez
Seattle Genetics
Adcetris
Antares
Otrexup
Amag Pharmaceuticals
Feraheme
Cubist Pharmaceuticals
Entereg
Gilead
sofosbuvir
Amarin
Vascepa
Merck
suvorexant
Valeant Pharmaceuticals
efinaconazole
Depomed
Sefelsa
Zogenix
Zohydro
dabrafenib
tivozanib
Aveo Pharmaceuticals
Cubist Pharmaceuticals shares leap late after ruling on patent cases
Marketwatch
Tue, 05/21/13 - 11:49 am
patents
Cubist Pharmaceuticals
Hospira
Cubicin
antibiotics
generics
Trius Therapeutics: New, Positive Dimension For Investment Outlook
Seeking Alpha
Tue, 05/14/13 - 08:37 am
Trius Therapeutics
Teva
Cubist Pharmaceuticals
AstraZeneca, Cubist, Astellas Said to Make Bids for Optimer
Bloomberg
Tue, 05/14/13 - 08:38 am
Cubist Pharmaceuticals
Optimer
M&A
AstraZeneca
Astellas
Cubist says antibiotic regimen will get a fast-track review as a treatment for 3 infections
Yahoo/AP
Wed, 05/8/13 - 10:48 am
fast track
FDA
Cubist Pharmaceuticals
hospital-acquired bacterial pneumonia
antibiotics
This Week in Biotech
Motley Fool
Sun, 04/7/13 - 10:55 am
JNJ
Optimer
Biogen
Merck
Cubist Pharmaceuticals
AstraZeneca
Rigel Pharmaceuticals
AbbVie
Pfizer
Optimer Said to Draw Takeover Interest From Glaxo, Astellas
Bloomberg
Tue, 04/2/13 - 10:04 am
GSK
Astellas
M&A
Optimer Pharmaceuticals
AstraZeneca
Cubist Pharmaceuticals
Cubist Announces Exclusive Option to Acquire Adynxx
Yahoo
Mon, 02/25/13 - 10:10 am
Cubist Pharmaceuticals
Adynxx
AYX1
M&A
Trius Therapeutics: Takeover Candidate In 2013
Seeking Alpha
Mon, 02/4/13 - 12:13 pm
Trius Therapeutics
Cubist Pharmaceuticals
M&A
Cubist Pharma Earnings: A Mixed Reaction to Analyst Estimates
Wall St. Cheat Sheet
Thu, 01/24/13 - 10:27 am
earnings
Cubist Pharmaceuticals
Cubist Pharmaceuticals Inc Fourth Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Fri, 01/18/13 - 10:14 am
earnings
Cubist Pharmaceuticals
Cubist Pharma 4th-quarter revenue grows 16 percent as US sales of antibiotic improve
Yahoo/AP
Tue, 01/8/13 - 09:02 am
Cubist Pharmaceuticals
earnings
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
next ›
last »